Adenylate Cyclase-Calmodulin Protein Interaction Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current protein interaction detection methods, such as the BACTH system, suffer from low sensitivity due to high background noise and inability to discriminate between protein interactions based on affinity levels, and are not suitable for detecting high-affinity interactions involving toxic proteins or integral membrane proteins.
Innovation Solution
A method utilizing a low number of chimeric polypeptides with adenylate cyclase (AC) and calmodulin (CaM) where AC has a reduced affinity for CaM, allowing for the detection of high-affinity interactions by amplifying the cAMP signaling cascade, even with a single AC/CaM complex per cell, enabling the analysis of toxic proteins and integral membrane proteins.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If a high number of AC/CaM complexes are expressed in host cells, then the signal strength is sufficient for detection, but the background noise increases and sensitivity decreases
Solution Approach 1:
The patent modifies the affinity parameter of the AC-CaM interaction by introducing mutations in the AC enzyme or CaM protein that reduce their binding affinity. This parameter change allows the system to function with极低 concentrations of complexes, achieving single-molecule detection sensitivity. The reduced affinity prevents background noise while maintaining detectable signal through the amplification cascade.
Solution Approach 2:
The patent replaces a direct mechanical detection system (where AC/CaM complex formation directly produces a measurable signal) with a biochemical amplification system. The AC enzyme catalyzes cAMP production, which then activates a signaling cascade involving CRP and transcription factors, amplifying the initial single-molecule event into a detectable cellular response.
2Measurement precision
If AC and CaM have high affinity for each other, then the complex forms readily, but the system cannot discriminate between high and low affinity protein interactions
Solution Approach 1:
The patent changes the affinity parameter of the AC-CaM interaction from high to low through mutagenesis. This creates a system where only high-affinity protein-protein interactions (between the moieties of interest) can overcome the low AC-CaM affinity and produce sufficient cAMP signal. The parameter change enables discrimination: high-affinity interactions produce strong signals, while low-affinity interactions produce weak or no signals.
3Measurement precision
If toxic proteins are expressed at high levels, then sufficient signal is produced for detection, but the host cell viability is compromised
Solution Approach 1:
The patent replaces direct high-level expression detection with an amplified biochemical signaling system. By using the AC-cAMP-CRP transcriptional activation cascade, the system can detect极低 levels of toxic protein expression that would otherwise be insufficient for detection. The amplification allows sub-stoichiometric levels of toxic protein to produce detectable signals without killing the host cell.
4Stability of the object's composition
If the AC-CaM interaction is strengthened, then complex stability increases, but the system loses sensitivity for detecting high-affinity protein interactions
Solution Approach 1:
The patent inverts the stability-sensitivity relationship by reducing AC-CaM complex stability through mutagenesis. This creates a system where complex stability is low, but detection sensitivity is high. The unstable AC-CaM interaction ensures that only the most stable protein-protein interactions (high-affinity bindings between moieties of interest) can sustain enough complex formation to generate detectable cAMP signals above the noise threshold.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly enhances sensitivity, allowing for the detection of high-affinity protein interactions with reduced false positives and enabling the analysis of toxic proteins and integral membrane proteins, while maintaining the ability to confer a selectable trait to host cells with minimal AC/CaM complexes.
Implementation Method 1
involves the interaction-mediated reconstitution of a cyclic AMP (cAMP) signaling cascade
Implementation Method 2
amplifying the cAMP signaling cascade
Implementation Method 3
cAMP binds to the catabolite activator protein (CAP or CRP) and triggers the transcriptional activation
Implementation Method 4
Most biological processes involve specific protein-protein interactions (PPIs)
Data Source
AI summary
The present invention relates to a method to detect the interaction between a target ligand and a moiety of interest using an adenylate cyclase enzyme (AC) and calmodulin (CaM) as interacting partners, said method comprising:i) expressing in a suitable host cell:(a) a low number of molecules of a first chimeric polypeptide containing AC, and(b) a low number of molecules of a second chimeric polypeptide containing CaM,wherein said AC in said first chimeric polypeptide and/or said CaM in said second chimeric polypeptide has decreased affinity for its interacting partner,wherein said AC in said first chimeric polypeptide is fused to a moiety of interest and said CaM in said second chimeric polypeptide is fused to a target ligand, or conversely,and wherein, when said moiety of interest and said target ligand interact, said AC is activated, andii) detecting the activation of said AC.The present inventors herein show that only one AC/CaM complex per cell is sufficient to confer a selectable trait to the host cell. Unexpectedly, even less than one AC/CaM complex per cell can be sufficient to confer a selectable trait to the host cell. This surprising result confers a very high sensitivity, that is helpful for screening high affinity interactions, such as antigen-antibody interactions. Moreover, the low expression of the chimeric proteins that is achieved in the present invention allows to characterize toxic moieties, what was not possible before.